Global investment firm KKR has agreed to acquire Integer Holdings Corporation, a leading manufacturer of medical devices and components used in cardiovascular, neuromodulation, and orthopedic products. Under the agreement, Integer shareholders will receive US$127 per share in cash, representing a premium over the company's previous market price.
Integer is a major supplier to some of the world's largest healthcare and medical device companies, producing components for pacemakers, neurostimulators, catheters, and other life-saving technologies. KKR said the acquisition will provide the long-term investment needed to expand Integer's manufacturing capabilities, accelerate innovation, and strengthen its global operations.
The transaction comes amid continued consolidation in the healthcare industry, where private equity firms and strategic investors are targeting companies that develop advanced medical technologies. Rising demand for medical devices, driven by aging populations and advances in healthcare, has made the sector increasingly attractive to investors.
Business analysts describe the acquisition as one of the largest healthcare buyouts of 2026. If completed, the deal is expected to enhance Integer's global growth strategy while reinforcing KKR's position as a major investor in healthcare, life sciences, and medical technology.
